Vaccinia derivatives were produced during the 1980s that could direct the synthesis of foreign proteins based on this principle; one could imagine using vaccinia or other vectors that carry multiple antigens to develop a single vaccine that would confer immunity against multiple infections at a very low cost per dose (e.g., $0.25).